Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?

被引:1294
作者
Baylin, SB [1 ]
Ohm, JE [1 ]
机构
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
关键词
D O I
10.1038/nrc1799
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromatin alterations have been associated with all stages of tumour formation and progression. The best characterized are epigenetically mediated transcriptional-silencing events that are associated with increases in DNA methylation - particularly at promoter regions of genes that regulate important cell functions. Recent evidence indicates that epigenetic changes might 'addict' cancer cells to altered signal-transduction pathways during the early stages of tumour development. Dependence on these pathways for cell proliferation or survival allows them to acquire genetic mutations in the same pathways, providing the cell with selective advantages that promote tumour progression. Strategies to reverse epigenetic gene silencing might therefore be useful in cancer prevention and therapy.
引用
收藏
页码:107 / 116
页数:10
相关论文
共 123 条
[21]   The induction of aberrant crypt foci (ACF) in the colons of rats by trihalomethanes administered in the drinking water [J].
DeAngelo, AB ;
Geter, DR ;
Rosenberg, DW ;
Crary, CK ;
George, MH .
CANCER LETTERS, 2002, 187 (1-2) :25-31
[22]   Epigenetics in human disease and prospects for epigenetic therapy [J].
Egger, G ;
Liang, GN ;
Aparicio, A ;
Jones, PA .
NATURE, 2004, 429 (6990) :457-463
[23]  
Esteller M, 2000, CANCER RES, V60, P4366
[24]  
Esteller M, 2001, CANCER RES, V61, P4689
[25]  
Esteller M, 1999, CANCER RES, V59, P793
[26]  
Fahrner JA, 2002, CANCER RES, V62, P7213
[27]   Heterochromatin: stable and unstable invasions at home and abroad [J].
Fahrner, JA ;
Baylin, SB .
GENES & DEVELOPMENT, 2003, 17 (15) :1805-1812
[28]   Timeline - The history of cancer epigenetics [J].
Feinberg, AP ;
Tycko, B .
NATURE REVIEWS CANCER, 2004, 4 (02) :143-153
[29]   Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action [J].
Finch, PW ;
He, X ;
Kelley, MJ ;
Uren, A ;
Schaudies, RP ;
Popescu, NC ;
Rudikoff, S ;
Aaronson, SA ;
Varmus, HE ;
Rubin, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) :6770-6775
[30]   Histone and chromatin cross-talk [J].
Fischle, W ;
Wang, YM ;
Allis, CD .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :172-183